Cargando…

Base rate of ovarian cancer on algorithms in patients with a pelvic mass

OBJECTIVE: Algorithms have been developed to identify ovarian cancer in women with a pelvic mass. The aim of this study was to determine how the base rates of ovarian cancer influence the case finding abilities of recently developed algorithms applicable to pelvic tumors. We used three ovarian cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Rolfsen, Anne Lone Denny, Dahl, Alv A, Pripp, Are Hugo, Dørum, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656145/
https://www.ncbi.nlm.nih.gov/pubmed/32699016
http://dx.doi.org/10.1136/ijgc-2020-001416
_version_ 1783608320501743616
author Rolfsen, Anne Lone Denny
Dahl, Alv A
Pripp, Are Hugo
Dørum, Anne
author_facet Rolfsen, Anne Lone Denny
Dahl, Alv A
Pripp, Are Hugo
Dørum, Anne
author_sort Rolfsen, Anne Lone Denny
collection PubMed
description OBJECTIVE: Algorithms have been developed to identify ovarian cancer in women with a pelvic mass. The aim of this study was to determine how the base rates of ovarian cancer influence the case finding abilities of recently developed algorithms applicable to pelvic tumors. We used three ovarian cancer algorithms and the principle of Bayes’ theorem for risk estimation. METHODS: First, we evaluated the case finding abilities of the Risk of Malignancy Algorithm, the Rajavithi–Ovarian Predictive Score, and the Copenhagen Index in a prospectively collected sample at Oslo University Hospital of 227 postmenopausal women with a 74% base rate of ovarian cancer. Second, we examined the case finding abilities of the Risk of Malignancy Algorithm in three published studies with different base rates of ovarian cancer. We applied Bayes’ theorem in these examinations. RESULTS: In the Oslo sample, all three algorithms functioned poorly as case finders for ovarian cancer. When the base rate changed from 8.2% to 43.8% in the three studies using the Risk of Malignancy Algorithm, the proportion of false negative ovarian cancer diagnoses increased from 1.2% to 3.4%, and the number of false positive diagnosis increased from 4.6% to 14.2%. CONCLUSION: This study demonstrated that the base rate of ovarian cancer in the samples tested was important for the case finding abilities of algorithms.
format Online
Article
Text
id pubmed-7656145
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-76561452020-11-17 Base rate of ovarian cancer on algorithms in patients with a pelvic mass Rolfsen, Anne Lone Denny Dahl, Alv A Pripp, Are Hugo Dørum, Anne Int J Gynecol Cancer Original Research OBJECTIVE: Algorithms have been developed to identify ovarian cancer in women with a pelvic mass. The aim of this study was to determine how the base rates of ovarian cancer influence the case finding abilities of recently developed algorithms applicable to pelvic tumors. We used three ovarian cancer algorithms and the principle of Bayes’ theorem for risk estimation. METHODS: First, we evaluated the case finding abilities of the Risk of Malignancy Algorithm, the Rajavithi–Ovarian Predictive Score, and the Copenhagen Index in a prospectively collected sample at Oslo University Hospital of 227 postmenopausal women with a 74% base rate of ovarian cancer. Second, we examined the case finding abilities of the Risk of Malignancy Algorithm in three published studies with different base rates of ovarian cancer. We applied Bayes’ theorem in these examinations. RESULTS: In the Oslo sample, all three algorithms functioned poorly as case finders for ovarian cancer. When the base rate changed from 8.2% to 43.8% in the three studies using the Risk of Malignancy Algorithm, the proportion of false negative ovarian cancer diagnoses increased from 1.2% to 3.4%, and the number of false positive diagnosis increased from 4.6% to 14.2%. CONCLUSION: This study demonstrated that the base rate of ovarian cancer in the samples tested was important for the case finding abilities of algorithms. BMJ Publishing Group 2020-11 2020-07-21 /pmc/articles/PMC7656145/ /pubmed/32699016 http://dx.doi.org/10.1136/ijgc-2020-001416 Text en © IGCS and ESGO 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Original Research
Rolfsen, Anne Lone Denny
Dahl, Alv A
Pripp, Are Hugo
Dørum, Anne
Base rate of ovarian cancer on algorithms in patients with a pelvic mass
title Base rate of ovarian cancer on algorithms in patients with a pelvic mass
title_full Base rate of ovarian cancer on algorithms in patients with a pelvic mass
title_fullStr Base rate of ovarian cancer on algorithms in patients with a pelvic mass
title_full_unstemmed Base rate of ovarian cancer on algorithms in patients with a pelvic mass
title_short Base rate of ovarian cancer on algorithms in patients with a pelvic mass
title_sort base rate of ovarian cancer on algorithms in patients with a pelvic mass
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656145/
https://www.ncbi.nlm.nih.gov/pubmed/32699016
http://dx.doi.org/10.1136/ijgc-2020-001416
work_keys_str_mv AT rolfsenannelonedenny baserateofovariancanceronalgorithmsinpatientswithapelvicmass
AT dahlalva baserateofovariancanceronalgorithmsinpatientswithapelvicmass
AT pripparehugo baserateofovariancanceronalgorithmsinpatientswithapelvicmass
AT dørumanne baserateofovariancanceronalgorithmsinpatientswithapelvicmass